The Board of Directors of Tata Chemicals is scheduled to meet on February 2, 2026, to review and approve the Unaudited Consolidated and Audited Standalone Financial Results for the third quarter (Oct-Dec) and nine months ended December 31, 2025. The company has also announced a trading window closure for designated persons from December 25, 2025, to February 4, 2026.
Board Meeting Announcement
Tata Chemicals has announced that a meeting of its Board of Directors will be convened on Monday, February 2, 2026. The primary agenda of the meeting is to consider and approve the Unaudited Consolidated and Audited Standalone Financial Results of the company.
Financial Results on the Agenda
The Board will specifically address the financial performance for the third quarter (Q3: Oct-Dec) and the nine-month period ending on December 31, 2025. These results will provide insights into the company’s performance during this period.
Trading Window Closure
In compliance with insider trading regulations, Tata Chemicals has declared a trading window closure for its designated persons. The closure period commenced on Thursday, December 25, 2025, and will remain in effect until Wednesday, February 4, 2026 (both days inclusive). This measure ensures fair trading practices and prevents any potential misuse of unpublished price-sensitive information.
Source: BSE
